SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-12-001366
Filing Date
2012-02-23
Accepted
2012-02-23 16:01:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a2207514z424b5.htm 424B5 456977
2 G148431.JPG g148431.jpg GRAPHIC 16723
  Complete submission text file 0001047469-12-001366.txt   481306
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-165899 | Film No.: 12633849
SIC: 2835 In Vitro & In Vivo Diagnostic Substances